Exceptional 89.5% growth masks sequential softness, margin headwinds ahead
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade A-
On track vs FY27 14-15% EBITDA guidance (Q1 at 14.8%). Sequential softness and acknowledged margin headwinds suggest H2 execution risk; needs monitoring post-half year.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Exceptional 89.5% YoY revenue and 332.5% PAT growth supported by CP PLUS dominance and post-IPO finance cost deleveraging; sequential softness (-1.4% revenue, -15.9% PAT QoQ) and exhausted low-cost inventory signal near-term margin compression. Guidance (14-15% EBITDA) reaffirmed but dependent on gradual price-pass execution and demand stability into H2.
₹1402.4 Cr
Revenue · +89.5% YoY₹142.2 Cr
Reported PAT · +332.5% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Revenue 89.5% YoY driven by CP PLUS momentum
MET₹1,402.4 Cr delivered; growth figure accurate; CP PLUS 87% of revenue
PAT up 332.5% YoY to ₹142.2 Cr
MET₹142.2 Cr delivered; 59% finance cost reduction is primary driver post-IPO
Gross margin 30.8%, up 810 bps; EBITDA 14.8% up 604 bps
METFigures match; margin expansion real but driven by low-cost inventory burn now exhausted
Market share 43.3%, position effectively doubled
UnverifiedPer Frost & Sullivan FY26; prior year baseline not independently verified in call
Margins moderated from Q4 due to inventory exhaustion
METQ1 QoQ shows revenue -1.4%, PAT -15.9%; acknowledged headwind
Earnings quality
What changed since the last call
Inventory cost tailwind now exhausted
DowngradeQ4 benefited from low-cost inventory burn; depleted by April 2026. Forward margin depends on ASP realization and product mix, not inventory arbitrage.
Price hike cadence gradual, not aggressive
Neutral10-20% taken Q1, targeting 25% full year; phased monthly/quarterly increases to avoid demand shock. Timing gap between cost inflation and price pass creates H2 risk.
EBITDA guidance maintained at 14-15%
MaintainedDespite QoQ softness and acknowledged cost headwinds, management reaffirmed FY27 EBITDA guidance without change; suggests confidence in H2 recovery or conservative initial target.
Capacity utilization high at 85-90%
NeutralJustifies capex need; 2.5M units/month current capacity to double over 3 years. Supply-side constraint if demand accelerates.
The Q&A
Analysts pressed hard on moat durability vs. 40+ STQC-certified competitors, sourcing concentration (35% Taiwan semiconductors), margin sustainability post-inventory, and new category TAM credibility. Management answered directly without deflection; stood firm on guidance. Provided tactical specifics (10-20% price hikes taken, 85-90% utilization, 3-4 quarter chip coverage). No defensive tone or hedging, but acknowledged real headwinds.
Price hikes and margins — Dhruv Jain, Ambit Institutional Equities
Answered10-20% price increases taken product-wise so far. Targeting 25% for full year via gradual monthly or quarterly increases to avoid demand shock.
Backward integration uplift — Dhruv Jain, Ambit
PartialWill have basis point additions; difficult to quantify today. Scale of manufacturing and localization will drive strengths over time.
New category TAM — Naushad Chaudhary, Aditya Birla Sun Life
PartialHope it's ₹5,000-10,000 Cr. Early stage, good adjacencies, but cannot comment quantitatively today.
Moat durability vs competition — Anuj Kashyap, A3 Capital
AnsweredMultiple moats: brand (synonymous with category), distribution reach, manufacturing unparalleled (3rd largest globally), R&D, management depth. CCTV is priority sector; no policy deviation expected.
Cable JV revenue contribution — Mudit Bhandari, IIFL Capital
AnsweredNot less than 5% of CP PLUS revenue as attached accessories business. Second stage adds single-digit BOM optimization.
BOM sourcing and localization — Saurabh Shah, AUM Fund Advisors
Answered35% from Taiwan semiconductors; 15-20% passive electronics (Taiwan/China); housing, cables, lenses localizing. Target 55-60% import, 40% domestic post-Q3-Q4.
Forex hedging mechanics — Saurabh Shah, AUM
Answered85-100% hedging policy reviewed by board; currently 90%+ forex covers. Blocks shipments weekly to manage exposure.
Chinese component ban impact — Sargam Garg, ICICI Bank
AnsweredSTQC norm came April 2025 (not 2026). April 1 2026 was inventory clearance deadline. Transition completed; 40+ brands now certified. Smaller players struggling; we benefit from scale.
Capacity and capex — Shubham Thorat, Perpetual Capital
Answered2.5M units/month, 85-90% utilization. Capacity doubling over 3 years via Kadapa and Greater Noida. Gradual quarter-on-quarter work-up.
Export potential — Udit Gajiwala, Motilal Oswal
AnsweredExport on table, 18-24 month timeline for significant revenue. After domestic supply resolution and field testing. Secondary priority now.
Chip sourcing security — Shreyansh Talesara, Equentis Wealth Advisors
AnsweredStrategy covers 3-4 quarters rolling forecast with vendors; not fixed March/June. Fairly comfortable with coverage and sourcing relationships.
Other expenses surge — Shreyansh Talesara, Equentis
AnsweredSeasonal marketing (IPL heavy in Q1, ~30-32% of annual spend). Inflationary appraisals. Nothing odd in the numbers.
Guidance
FY27 ₹6,000-6,500 Cr (50% growth from ~₹4,000 Cr base)
HighReaffirmed implicitly; on track at 89.5% YoY H1 run rate, but QoQ softness suggests H2 moderation needed
FY27 EBITDA 14-15%; PAT margins 8.5-9.5%
MediumReaffirmed despite headwinds; Q1 at 14.8% EBITDA, 10.1% PAT near top-end. Price-pass timing and margin compression risk in H2.
Capacity doubling over 3 years; housing, Kadapa, Greater Noida expansions in progress
MediumHousing Q3 operational, Kadapa land final by year-end, Greater Noida land acquisition underway. Execution risk inherent.
Risks the call surfaced
Margin compression near-term
HighLow-cost inventory fully burned; gradual price-pass creates timing gap between cost inflation and revenue realization; QoQ softness signals demand elasticity
Supply chain concentration
Medium35% of BOM from Taiwan semiconductors (Japanese, Korean, American, Taiwanese fabs); subject to periodic supply shocks; rolling 3-4 quarter forecast creates near-term blind spot
Capacity execution risk
MediumCurrent 2.5M units/month at 85-90% utilization requires flawless capex execution for 3-year capacity doubling; delays or cost overruns could become bottleneck
New product commercialization
MediumCP PLUS Pro, Home IoT, industrial robotics, drone cameras all exploratory; TAM ₹5-10k Cr speculative without market research; Q4 launch target at risk
Competitive moat durability
Low43.3% market share is strong but 40+ STQC-certified brands compete; Chinese import ban (April 2025) provides protection but could reverse; value proposition must sustain pricing power if commoditization pressure rises
Management
Score 8/10. Clear and direct. Addressed tough questions on competition, sourcing, and margins without deflection. Provided granular specifics (10-20% price hikes, 85-90% utilization, 3-4 quarter chip coverage). Candid about headwinds (inventory exhaustion, gradual pass-through). No NDA shields used; acknowledged real constraints. Strong track record. Delivered Q1 targets: ₹1,402 Cr revenue and ₹142.2 Cr PAT as reported. EBITDA 14.8% within guidance. Manufacturing scaled (42 FA, 4 MI, 12 SMT lines). Market share expanded to 43.3%. Prior guidance (14-15% EBITDA) reaffirmed despite headwinds.
1 · Q3-Q4 FY27
CP PLUS Pro (enterprise) and Home IoT product launches; margin impact TBD
2 · Q3 FY27
Housing enclosure backward integration facility comes online
3 · FY27 year-end
Corelink cable JV commercial production; Kadapa land acquisition finalized
Guidance (14-15% EBITDA) reaffirmed but dependent on gradual price-pass execution and demand stability into H2.
Informational and educational content only. Not investment advice.